Showing results (2991-3000 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|February 12, 2020
De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs RegistryDebu Tripathy, Adam Brufsky, Melody Cobleigh, et al.The Oncologist|February 12, 2020
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF-MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System InvolvementMatteo Claudio Da Vià, Antonio Giovanni Solimando, Andoni Garitano-Trojaola, et al.The Oncologist|February 12, 2020
Lymph Node Imaging in Patients with Primary Breast Cancer: Concurrent Diagnostic ToolsMaria Adele Marino, Daly Avendano, Pedro Zapata, et al.The Oncologist|February 13, 2020
Anti-PD1-Induced Immune-Related Adverse Events and Survival Outcomes in Advanced MelanomaAleksi Suo, Yin Chan, Carissa Beaulieu, et al.The Oncologist|February 13, 2020
Phase Ib Study of Crizotinib plus Pembrolizumab in Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer with ALK TranslocationSandip Pravin Patel, Suchita Pakkala, Nathan A Pennell, et al.The Oncologist|February 15, 2020
Is Adjuvant Chemotherapy Necessary for Patients with Deficient Mismatch Repair Gastric Cancer?-Autophagy Inhibition Matches the MismatchedChun-Yi Tsai, Tien-An Lin, Shih-Chiang Huang, et al.The Oncologist|January 17, 2020
Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based AnalysisHuixun Jia, Qingguo Li, Jing Yuan, et al.The Oncologist|January 17, 2020
Immune-Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration-Approved Indications for ImmunotherapySatya Das, Kristen K Ciombor, Sigurdis Haraldsdottir, et al.The Oncologist|January 17, 2020
A Systematic Review of Pediatric Phase I Trials in Oncology: Toxicity and Outcomes in the Era of Targeted TherapiesJulia W Cohen, Srivandana Akshintala, Eli Kane, et al.Pageof 571